If we now look in the literature to see how our results fit with what has already been published, we find that in terms of sex differences, female sex is a known risk factor for the development of autoimmune diseases, especially autoimmune hepatic diseases [19], and is linked to the occurrence of IRAE during Anti-CTLA-4 monotherapy [6]. Here, CTLA4 is linked to autoimmune disease.